Clinical Research Directory
Browse clinical research sites, groups, and studies.
Real-world Ruxolitinib Experience in PV
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Summary
This is a multicentric, observational, retro-prospective study in adult PV patients - resistant or intolerant to hydroxyurea - who are going to receive or have already initiated treatment with ruxolitinib according to the approved local label. Enrolment will last 9 months after the first enrolled patient. Patients will be observed for a minimum of 3 months, in order to evaluate the primary endpoint for all patients.
Official title: Real-world Ruxolitinib Experience in Polycythemia Vera: REVIEW Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
153
Start Date
2024-07
Completion Date
2025-07
Last Updated
2024-05-09
Healthy Volunteers
Not specified